Skip to main content
Acecare 2 mg/ml Solution for Injection for Dogs and Cats
  • Acepromazīna maleāts
  • Valid
Authorised in these countries:
  • Ireland

Product identification

Medicine name:
Acecare 2 mg/ml Solution for Injection for Dogs and Cats
Acecare 2 mg/ml Solution for Injection for Dogs and Cats
Active substance and strength:
  • Acepromazīna maleāts
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05AA04
Authorisation number:
  • VPA10491/009/001
Product identification number:
  • 8bbd198c-cbaa-4984-bc99-a7c80655ca89
Permanent identification number:
  • 600000050434

Product details

Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat

Availability

Package description:
  • 20 ml clear glass (Type II) vial. Closed with a grey bromobutyl coated rubber bung and aluminium crimped seal.
    Available in these countries:
    • Ireland
Manufacturing sites for batch release:
This information is not available for this product.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • IE/V/0459/001
Date of authorisation status change:
Authorisation country:
  • Ireland
Responsible authority:
  • HPRA
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation issued:
Reference member state:
  • Ireland
Concerned member states:
  • United Kingdom (Northern Ireland)
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."